Structure

Physi-Chem Properties

Molecular Weight:  608.25
Volume:  589.028
LogP:  -0.211
LogD:  -0.29
LogS:  -2.454
# Rotatable Bonds:  14
TPSA:  215.83
# H-Bond Aceptor:  13
# H-Bond Donor:  8
# Rings:  4
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.133
Synthetic Accessibility Score:  4.584
Fsp3:  0.567
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.286
MDCK Permeability:  8.918986168282572e-06
Pgp-inhibitor:  0.01
Pgp-substrate:  0.986
Human Intestinal Absorption (HIA):  0.996
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.17
Plasma Protein Binding (PPB):  67.83076477050781%
Volume Distribution (VD):  0.177
Pgp-substrate:  13.17568588256836%

ADMET: Metabolism

CYP1A2-inhibitor:  0.021
CYP1A2-substrate:  0.017
CYP2C19-inhibitor:  0.039
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.018
CYP2C9-substrate:  0.56
CYP2D6-inhibitor:  0.021
CYP2D6-substrate:  0.223
CYP3A4-inhibitor:  0.009
CYP3A4-substrate:  0.051

ADMET: Excretion

Clearance (CL):  1.354
Half-life (T1/2):  0.876

ADMET: Toxicity

hERG Blockers:  0.462
Human Hepatotoxicity (H-HT):  0.161
Drug-inuced Liver Injury (DILI):  0.019
AMES Toxicity:  0.289
Rat Oral Acute Toxicity:  0.265
Maximum Recommended Daily Dose:  0.041
Skin Sensitization:  0.908
Carcinogencity:  0.256
Eye Corrosion:  0.003
Eye Irritation:  0.063
Respiratory Toxicity:  0.03

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471066

Natural Product ID:  NPC471066
Common Name*:   (5S)-5-Hydroxy-1,7-Bis-(4-Hydroxyphenyl)-3-Heptanone-5-O-Beta-D-Apiofuranosyl-(1->6)-Beta-D-Glucopyranoside
IUPAC Name:   (5S)-5-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-1,7-bis(4-hydroxyphenyl)heptan-3-one
Synonyms:  
Standard InCHIKey:  UGYZLORFQGTFRN-SHYGZIMPSA-N
Standard InCHI:  InChI=1S/C30H40O13/c31-14-22-24(35)27(38)29(42-22)40-15-23-25(36)26(37)28(39)30(43-23)41-21(12-6-17-3-9-19(33)10-4-17)13-20(34)11-5-16-1-7-18(32)8-2-16/h1-4,7-10,21-33,35-39H,5-6,11-15H2/t21-,22+,23+,24+,25+,26-,27+,28+,29+,30+/m0/s1
SMILES:  C1=CC(=CC=C1CCC(CC(=O)CCC2=CC=C(C=C2)O)OC3C(C(C(C(O3)COC4C(C(C(O4)CO)O)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2346810
PubChem CID:   71720155
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids
          • [CHEMONTID:0000356] Curcuminoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32876 alnus hirsuta f. sibirica Species Betulaceae Eukaryota n.a. n.a. n.a. PMID[23465614]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT520 Cell Line 3T3-L1 Mus musculus Activity = 24.8 % PMID[490551]
NPT520 Cell Line 3T3-L1 Mus musculus Activity = 34.6 % PMID[490551]
NPT520 Cell Line 3T3-L1 Mus musculus Activity = 88.4 % PMID[490551]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471066 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC471095
0.9921 High Similarity NPC164172
0.984 High Similarity NPC470122
0.984 High Similarity NPC17968
0.984 High Similarity NPC469705
0.968 High Similarity NPC158673
0.9615 High Similarity NPC469696
0.9453 High Similarity NPC476407
0.92 High Similarity NPC471067
0.9167 High Similarity NPC180171
0.9167 High Similarity NPC103398
0.9167 High Similarity NPC158325
0.9127 High Similarity NPC178449
0.9127 High Similarity NPC470907
0.9127 High Similarity NPC232454
0.904 High Similarity NPC469703
0.904 High Similarity NPC201402
0.904 High Similarity NPC160854
0.904 High Similarity NPC469704
0.8968 High Similarity NPC469686
0.8905 High Similarity NPC148080
0.8905 High Similarity NPC469623
0.8855 High Similarity NPC469549
0.8846 High Similarity NPC469687
0.881 High Similarity NPC469702
0.881 High Similarity NPC282409
0.8741 High Similarity NPC123988
0.874 High Similarity NPC476448
0.874 High Similarity NPC476445
0.874 High Similarity NPC469548
0.8722 High Similarity NPC478255
0.8705 High Similarity NPC478250
0.8676 High Similarity NPC471345
0.8636 High Similarity NPC225307
0.8613 High Similarity NPC310252
0.8613 High Similarity NPC100558
0.8613 High Similarity NPC302583
0.8613 High Similarity NPC84789
0.8582 High Similarity NPC281798
0.8561 High Similarity NPC264900
0.8561 High Similarity NPC288416
0.8561 High Similarity NPC231607
0.8561 High Similarity NPC108659
0.8561 High Similarity NPC79715
0.855 High Similarity NPC123704
0.8531 High Similarity NPC473138
0.8531 High Similarity NPC28776
0.8531 High Similarity NPC120728
0.8527 High Similarity NPC55608
0.8521 High Similarity NPC212808
0.8492 Intermediate Similarity NPC148055
0.8485 Intermediate Similarity NPC94179
0.848 Intermediate Similarity NPC157338
0.8462 Intermediate Similarity NPC469927
0.8444 Intermediate Similarity NPC235294
0.8444 Intermediate Similarity NPC46137
0.8433 Intermediate Similarity NPC184092
0.8414 Intermediate Similarity NPC35097
0.8403 Intermediate Similarity NPC116229
0.8397 Intermediate Similarity NPC236981
0.8394 Intermediate Similarity NPC169398
0.838 Intermediate Similarity NPC194938
0.838 Intermediate Similarity NPC296659
0.838 Intermediate Similarity NPC202391
0.8333 Intermediate Similarity NPC470330
0.8322 Intermediate Similarity NPC475528
0.8321 Intermediate Similarity NPC28637
0.8309 Intermediate Similarity NPC246869
0.8309 Intermediate Similarity NPC138777
0.8309 Intermediate Similarity NPC225384
0.8286 Intermediate Similarity NPC171134
0.8286 Intermediate Similarity NPC324262
0.8286 Intermediate Similarity NPC62800
0.8286 Intermediate Similarity NPC321638
0.8286 Intermediate Similarity NPC328273
0.8286 Intermediate Similarity NPC321184
0.8284 Intermediate Similarity NPC471881
0.8284 Intermediate Similarity NPC471882
0.8284 Intermediate Similarity NPC156692
0.8284 Intermediate Similarity NPC45224
0.8284 Intermediate Similarity NPC173150
0.8284 Intermediate Similarity NPC35288
0.8271 Intermediate Similarity NPC90318
0.8271 Intermediate Similarity NPC83218
0.8271 Intermediate Similarity NPC126991
0.8264 Intermediate Similarity NPC143246
0.8264 Intermediate Similarity NPC119773
0.8264 Intermediate Similarity NPC474268
0.8264 Intermediate Similarity NPC475539
0.8264 Intermediate Similarity NPC473147
0.8248 Intermediate Similarity NPC254275
0.8243 Intermediate Similarity NPC245615
0.8243 Intermediate Similarity NPC257847
0.8243 Intermediate Similarity NPC61604
0.8243 Intermediate Similarity NPC259182
0.8243 Intermediate Similarity NPC121001
0.8243 Intermediate Similarity NPC299706
0.8243 Intermediate Similarity NPC115466
0.8243 Intermediate Similarity NPC87403
0.824 Intermediate Similarity NPC177576
0.8222 Intermediate Similarity NPC148982
0.8219 Intermediate Similarity NPC287294
0.8214 Intermediate Similarity NPC101686
0.8214 Intermediate Similarity NPC469364
0.8214 Intermediate Similarity NPC65262
0.8209 Intermediate Similarity NPC471157
0.8209 Intermediate Similarity NPC252114
0.8209 Intermediate Similarity NPC61181
0.8203 Intermediate Similarity NPC473556
0.8203 Intermediate Similarity NPC301651
0.8203 Intermediate Similarity NPC175771
0.8201 Intermediate Similarity NPC263829
0.82 Intermediate Similarity NPC265480
0.82 Intermediate Similarity NPC478055
0.82 Intermediate Similarity NPC149368
0.8189 Intermediate Similarity NPC313193
0.8188 Intermediate Similarity NPC160882
0.8188 Intermediate Similarity NPC106625
0.8182 Intermediate Similarity NPC52097
0.8176 Intermediate Similarity NPC106818
0.8163 Intermediate Similarity NPC12006
0.8163 Intermediate Similarity NPC158635
0.8163 Intermediate Similarity NPC229882
0.816 Intermediate Similarity NPC252544
0.816 Intermediate Similarity NPC321252
0.8158 Intermediate Similarity NPC130489
0.8158 Intermediate Similarity NPC200708
0.8158 Intermediate Similarity NPC208676
0.8156 Intermediate Similarity NPC220942
0.8151 Intermediate Similarity NPC472339
0.8148 Intermediate Similarity NPC106677
0.8148 Intermediate Similarity NPC103533
0.8146 Intermediate Similarity NPC122809
0.8143 Intermediate Similarity NPC470572
0.8143 Intermediate Similarity NPC472132
0.8138 Intermediate Similarity NPC291153
0.8133 Intermediate Similarity NPC99233
0.8133 Intermediate Similarity NPC97052
0.8133 Intermediate Similarity NPC169248
0.8133 Intermediate Similarity NPC39351
0.8133 Intermediate Similarity NPC26195
0.8133 Intermediate Similarity NPC72649
0.8133 Intermediate Similarity NPC131532
0.8133 Intermediate Similarity NPC38699
0.8129 Intermediate Similarity NPC886
0.8129 Intermediate Similarity NPC287597
0.8129 Intermediate Similarity NPC34293
0.8125 Intermediate Similarity NPC63304
0.8121 Intermediate Similarity NPC259767
0.8121 Intermediate Similarity NPC88484
0.8108 Intermediate Similarity NPC474620
0.8106 Intermediate Similarity NPC11724
0.8106 Intermediate Similarity NPC266045
0.8095 Intermediate Similarity NPC96599
0.8085 Intermediate Similarity NPC260425
0.8079 Intermediate Similarity NPC206378
0.8079 Intermediate Similarity NPC163635
0.8079 Intermediate Similarity NPC170475
0.8079 Intermediate Similarity NPC127406
0.8067 Intermediate Similarity NPC83283
0.8067 Intermediate Similarity NPC143851
0.8067 Intermediate Similarity NPC476194
0.8067 Intermediate Similarity NPC29763
0.8067 Intermediate Similarity NPC39360
0.8067 Intermediate Similarity NPC210003
0.8058 Intermediate Similarity NPC114116
0.8056 Intermediate Similarity NPC40305
0.8056 Intermediate Similarity NPC105005
0.8047 Intermediate Similarity NPC285350
0.8042 Intermediate Similarity NPC472711
0.8041 Intermediate Similarity NPC240592
0.8041 Intermediate Similarity NPC117346
0.8039 Intermediate Similarity NPC271270
0.8039 Intermediate Similarity NPC142860
0.8039 Intermediate Similarity NPC97285
0.8039 Intermediate Similarity NPC246469
0.803 Intermediate Similarity NPC476872
0.8029 Intermediate Similarity NPC11025
0.8029 Intermediate Similarity NPC214246
0.8029 Intermediate Similarity NPC253595
0.8028 Intermediate Similarity NPC68092
0.8028 Intermediate Similarity NPC197316
0.8028 Intermediate Similarity NPC81515
0.8028 Intermediate Similarity NPC64141
0.8028 Intermediate Similarity NPC220936
0.8028 Intermediate Similarity NPC476383
0.8028 Intermediate Similarity NPC89105
0.8028 Intermediate Similarity NPC31745
0.8028 Intermediate Similarity NPC205195
0.8028 Intermediate Similarity NPC472350
0.8026 Intermediate Similarity NPC288084
0.8026 Intermediate Similarity NPC23817
0.8026 Intermediate Similarity NPC177742
0.8026 Intermediate Similarity NPC197896
0.8026 Intermediate Similarity NPC156457
0.8026 Intermediate Similarity NPC161749
0.8026 Intermediate Similarity NPC6985
0.8026 Intermediate Similarity NPC43638
0.8026 Intermediate Similarity NPC313163
0.8026 Intermediate Similarity NPC258035

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471066 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8028 Intermediate Similarity NPD7266 Discontinued
0.8026 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD3818 Discontinued
0.7712 Intermediate Similarity NPD8455 Phase 2
0.7688 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD6559 Discontinued
0.764 Intermediate Similarity NPD7074 Phase 3
0.7632 Intermediate Similarity NPD4380 Phase 2
0.7578 Intermediate Similarity NPD7054 Approved
0.7531 Intermediate Similarity NPD7472 Approved
0.7516 Intermediate Similarity NPD7228 Approved
0.745 Intermediate Similarity NPD6190 Approved
0.7448 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7445 Intermediate Similarity NPD1091 Approved
0.7439 Intermediate Similarity NPD7251 Discontinued
0.7419 Intermediate Similarity NPD37 Approved
0.7405 Intermediate Similarity NPD6234 Discontinued
0.7394 Intermediate Similarity NPD7808 Phase 3
0.7389 Intermediate Similarity NPD4966 Approved
0.7389 Intermediate Similarity NPD4965 Approved
0.7389 Intermediate Similarity NPD4967 Phase 2
0.7378 Intermediate Similarity NPD6797 Phase 2
0.7351 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD7075 Discontinued
0.7299 Intermediate Similarity NPD5125 Phase 3
0.7299 Intermediate Similarity NPD5126 Approved
0.7297 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6233 Phase 2
0.7289 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD7033 Discontinued
0.7248 Intermediate Similarity NPD1549 Phase 2
0.7246 Intermediate Similarity NPD8312 Approved
0.7246 Intermediate Similarity NPD8313 Approved
0.7222 Intermediate Similarity NPD6798 Discontinued
0.7222 Intermediate Similarity NPD3764 Approved
0.7197 Intermediate Similarity NPD1934 Approved
0.7192 Intermediate Similarity NPD6355 Discontinued
0.7171 Intermediate Similarity NPD5058 Phase 3
0.7152 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD4628 Phase 3
0.7152 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD3400 Discontinued
0.7126 Intermediate Similarity NPD7685 Pre-registration
0.7126 Intermediate Similarity NPD7240 Approved
0.7123 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD7199 Phase 2
0.7097 Intermediate Similarity NPD5403 Approved
0.7095 Intermediate Similarity NPD7097 Phase 1
0.7089 Intermediate Similarity NPD6801 Discontinued
0.7078 Intermediate Similarity NPD8389 Clinical (unspecified phase)
0.7077 Intermediate Similarity NPD5048 Discontinued
0.7073 Intermediate Similarity NPD6166 Phase 2
0.7073 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD3787 Discontinued
0.7055 Intermediate Similarity NPD6663 Approved
0.7052 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD1510 Phase 2
0.7034 Intermediate Similarity NPD3027 Phase 3
0.7014 Intermediate Similarity NPD5736 Approved
0.7007 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD1613 Approved
0.7 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.6987 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6984 Remote Similarity NPD2859 Approved
0.6984 Remote Similarity NPD2860 Approved
0.6968 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6968 Remote Similarity NPD5401 Approved
0.6957 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6944 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6944 Remote Similarity NPD5647 Approved
0.6943 Remote Similarity NPD1653 Approved
0.6939 Remote Similarity NPD4062 Phase 3
0.6933 Remote Similarity NPD5588 Approved
0.6929 Remote Similarity NPD2932 Approved
0.6929 Remote Similarity NPD3019 Approved
0.6918 Remote Similarity NPD7411 Suspended
0.6909 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6906 Remote Similarity NPD9545 Approved
0.6905 Remote Similarity NPD2934 Approved
0.6905 Remote Similarity NPD2933 Approved
0.6903 Remote Similarity NPD6799 Approved
0.6897 Remote Similarity NPD2861 Phase 2
0.6894 Remote Similarity NPD5402 Approved
0.6892 Remote Similarity NPD943 Approved
0.6892 Remote Similarity NPD1240 Approved
0.6886 Remote Similarity NPD3751 Discontinued
0.6875 Remote Similarity NPD3094 Phase 2
0.6863 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6861 Remote Similarity NPD2629 Approved
0.6859 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6852 Remote Similarity NPD3882 Suspended
0.6838 Remote Similarity NPD7843 Approved
0.6832 Remote Similarity NPD7819 Suspended
0.6832 Remote Similarity NPD2801 Approved
0.6831 Remote Similarity NPD1201 Approved
0.6831 Remote Similarity NPD1535 Discovery
0.6822 Remote Similarity NPD3020 Approved
0.6818 Remote Similarity NPD8166 Discontinued
0.6818 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6813 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6809 Remote Similarity NPD5238 Clinical (unspecified phase)
0.68 Remote Similarity NPD1607 Approved
0.6795 Remote Similarity NPD1511 Approved
0.6792 Remote Similarity NPD7458 Discontinued
0.679 Remote Similarity NPD3817 Phase 2
0.6786 Remote Similarity NPD1894 Discontinued
0.6783 Remote Similarity NPD1481 Phase 2
0.678 Remote Similarity NPD6534 Approved
0.678 Remote Similarity NPD6535 Approved
0.6776 Remote Similarity NPD9570 Approved
0.6776 Remote Similarity NPD2796 Approved
0.6776 Remote Similarity NPD2935 Discontinued
0.6765 Remote Similarity NPD969 Suspended
0.676 Remote Similarity NPD7700 Phase 2
0.676 Remote Similarity NPD7699 Phase 2
0.6759 Remote Similarity NPD1470 Approved
0.6755 Remote Similarity NPD4538 Approved
0.6755 Remote Similarity NPD4536 Approved
0.6755 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6753 Remote Similarity NPD6674 Discontinued
0.6752 Remote Similarity NPD7410 Clinical (unspecified phase)
0.675 Remote Similarity NPD6599 Discontinued
0.6743 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6741 Remote Similarity NPD3021 Approved
0.6741 Remote Similarity NPD3022 Approved
0.6735 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6735 Remote Similarity NPD4908 Phase 1
0.6732 Remote Similarity NPD6005 Phase 3
0.6732 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6732 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6732 Remote Similarity NPD6004 Phase 3
0.6732 Remote Similarity NPD6002 Phase 3
0.6722 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6713 Remote Similarity NPD3092 Approved
0.6713 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6713 Remote Similarity NPD1610 Phase 2
0.6713 Remote Similarity NPD3705 Approved
0.6712 Remote Similarity NPD2798 Approved
0.6711 Remote Similarity NPD5960 Phase 3
0.671 Remote Similarity NPD2575 Approved
0.671 Remote Similarity NPD3750 Approved
0.6709 Remote Similarity NPD1512 Approved
0.6703 Remote Similarity NPD6823 Phase 2
0.6691 Remote Similarity NPD7157 Approved
0.6689 Remote Similarity NPD6653 Approved
0.6689 Remote Similarity NPD7095 Approved
0.6689 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6688 Remote Similarity NPD5958 Discontinued
0.6688 Remote Similarity NPD2424 Discontinued
0.6685 Remote Similarity NPD6781 Approved
0.6685 Remote Similarity NPD6777 Approved
0.6685 Remote Similarity NPD6778 Approved
0.6685 Remote Similarity NPD6780 Approved
0.6685 Remote Similarity NPD6779 Approved
0.6685 Remote Similarity NPD6782 Approved
0.6685 Remote Similarity NPD6776 Approved
0.6667 Remote Similarity NPD7680 Approved
0.6667 Remote Similarity NPD5408 Approved
0.6667 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7435 Discontinued
0.6667 Remote Similarity NPD1548 Phase 1
0.6667 Remote Similarity NPD5404 Approved
0.6667 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5405 Approved
0.6667 Remote Similarity NPD2684 Approved
0.6667 Remote Similarity NPD5406 Approved
0.6649 Remote Similarity NPD7584 Approved
0.6646 Remote Similarity NPD7768 Phase 2
0.6646 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6644 Remote Similarity NPD2797 Approved
0.6644 Remote Similarity NPD3268 Approved
0.6644 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6644 Remote Similarity NPD1164 Approved
0.6643 Remote Similarity NPD3847 Discontinued
0.663 Remote Similarity NPD8319 Approved
0.663 Remote Similarity NPD8320 Phase 1
0.6629 Remote Similarity NPD6212 Phase 3
0.6629 Remote Similarity NPD6213 Phase 3
0.6629 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6629 Remote Similarity NPD8434 Phase 2
0.6629 Remote Similarity NPD8150 Discontinued
0.6627 Remote Similarity NPD7473 Discontinued
0.6627 Remote Similarity NPD5494 Approved
0.6623 Remote Similarity NPD4340 Discontinued
0.6623 Remote Similarity NPD230 Phase 1
0.6623 Remote Similarity NPD1933 Approved
0.6622 Remote Similarity NPD6832 Phase 2
0.6621 Remote Similarity NPD4659 Approved
0.6621 Remote Similarity NPD4379 Clinical (unspecified phase)
0.662 Remote Similarity NPD1357 Approved
0.6617 Remote Similarity NPD1237 Approved
0.6615 Remote Similarity NPD9495 Approved
0.6609 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6606 Remote Similarity NPD3749 Approved
0.66 Remote Similarity NPD6407 Approved
0.66 Remote Similarity NPD6405 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data